Today: 29 April 2026

Khadija Saeed

A dedicated markets reporter, she covers stocks, macroeconomics, and major business developments with a sharp eye for detail and accuracy.

SOFI Stock Today (11/20/2025): SoFi Technologies Slides After Huge 2025 Rally as Crypto Bank Bet Meets Rich Valuation

SOFI Stock Today (11/20/2025): SoFi Technologies Slides After Huge 2025 Rally as Crypto Bank Bet Meets Rich Valuation

SoFi Technologies shares fell 6.8% to $24.91 in late trading November 20, despite being up 89% year-to-date. The company reported record Q3 results, with GAAP net revenue of $962 million and its eighth straight profitable quarter. SoFi added 905,000 new members in Q3, reaching 12.6 million. On November 11, SoFi launched crypto trading inside its bank platform.
21 November 2025
···
Plug Power (PLUG) Stock Today, November 20, 2025: Price, $375M Debt Deal and AI Data Center Pivot Explained

Plug Power (PLUG) Stock Today, November 20, 2025: Price, $375M Debt Deal and AI Data Center Pivot Explained

Plug Power shares traded near $1.89 late Thursday, down 0.8% after a week-long slide of about 30%. The company priced $375 million in 6.75% convertible notes due 2033 to refinance debt, raising dilution concerns. Plug paused work on six U.S. hydrogen plants and a $1.66 billion DOE loan guarantee. Q3 revenue rose to $177 million, but heavy charges led to a GAAP loss.
20 November 2025
Opendoor (OPEN) Stock Today: Price, News, Warrant Dividend and Outlook – November 20, 2025

Opendoor (OPEN) Stock Today: Price, News, Warrant Dividend and Outlook – November 20, 2025

Opendoor Technologies shares fell 8% to $6.16 Thursday on heavy volume after a week of sharp declines, despite being up over 300% year-to-date. The company will issue three series of tradable warrants to shareholders on November 21. Fresh housing data showing a stalled U.S. market has renewed concerns about Opendoor’s inventory-heavy model. Q3 revenue beat forecasts, but the firm posted a $90 million net loss.
20 November 2025
··
Ondas Holdings (ONDS) Stock Today, November 20, 2025: Big Swings After $35 Million Combat Drone Deal and Share Authorization Vote

Ondas Holdings (ONDS) Stock Today, November 20, 2025: Big Swings After $35 Million Combat Drone Deal and Share Authorization Vote

Ondas Holdings shares fell 16% to $6.27 in late trading Thursday after a $35 million investment in combat drone maker PDW and a shareholder vote doubling authorized shares to 800 million. Volume surged to 114 million shares as ONDS swung between $6.25 and $7.98. The company reported Q3 revenue up 582% year over year but remains unprofitable.
20 November 2025
··
JOYY Stock Today, November 20, 2025: 6% Rally After Earnings Beat, Dividend Hike and Strong Ad Growth

JOYY Stock Today, November 20, 2025: 6% Rally After Earnings Beat, Dividend Hike and Strong Ad Growth

JOYY shares jumped over 6% Thursday, trading near $63.70 after the company posted Q3 2025 results, raised its dividend, and issued stronger revenue guidance. Net revenue rose 6.4% sequentially to $540.2 million, though still down from last year. Trading volume topped 1.2 million shares. JOYY stock is up more than 50% year-to-date and near its 52-week high.
20 November 2025
··
Abivax (ABVX) Stock Jumps on AstraZeneca Takeover Rumors: Outlook for November 20, 2025

Abivax (ABVX) Stock Jumps on AstraZeneca Takeover Rumors: Outlook for November 20, 2025

Abivax shares surged 8% to $121.94 Thursday afternoon on heavy volume after fresh takeover rumors involving AstraZeneca. The French biotech’s stock is up about 1,450% year-to-date, fueled by strong Phase 3 ulcerative colitis data and M&A speculation. No deal has been confirmed by either company. Intraday volume reached 3.75 million ADSs, far above recent averages.
20 November 2025
··
Kulicke & Soffa (KLIC) Jumps 11% After Q4 2025 Earnings Beat and Upbeat 2026 Guidance

Kulicke & Soffa (KLIC) Jumps 11% After Q4 2025 Earnings Beat and Upbeat 2026 Guidance

KLIC shares jumped 11% to around $39.23 Thursday after Kulicke & Soffa posted better-than-expected Q4 earnings and raised its outlook for early fiscal 2026. Volume neared 900,000 shares by early afternoon. Q4 revenue reached $177.6 million, down 2% year over year but up 20% sequentially. The move follows a 12% after-hours surge Wednesday after the company beat Wall Street estimates.
20 November 2025
1 … 760 761 762

Stock Market Today

  • TSX Picks: Aecon Group, Savaria Among Undervalued Stocks with Upside Potential
    April 29, 2026, 9:24 AM EDT. Investors eye undervalued TSX stocks amid volatile fuel prices and steady interest rates. Aecon Group (TSX:ARE), a CA$3.36 billion construction firm, trades 24.8% below estimated fair value, boosted by rising Q1 sales and a strong project pipeline. Savaria Corporation (TSX:SIS), specializing in accessibility solutions with a CA$2.15 billion market cap, is down 32.2% against fair value. Both companies show promising earnings growth projections, potentially rewarding investors as market conditions stabilize. These stocks highlight opportunities found through cash flow-based valuation methods amid an uncertain economic backdrop.

Latest article

Visa Stock Jumps as Earnings Beat and $20 Billion Buyback Ease Spending Fears

Visa Stock Jumps as Earnings Beat and $20 Billion Buyback Ease Spending Fears

29 April 2026
Visa shares jumped 5% premarket Wednesday after the company beat quarterly profit estimates, raised its full-year outlook, and announced a $20 billion buyback. Adjusted net income rose to $6.3 billion, or $3.31 a share, topping forecasts. Payments volume climbed 9%, cross-border volume 12%. Visa cited resilient consumer spending but flagged Middle East tensions as a risk to travel flows.
Regeneron Earnings Beat, But Eylea Still Clouds REGN Stock

Regeneron Earnings Beat, But Eylea Still Clouds REGN Stock

29 April 2026
Regeneron Pharmaceuticals reported first-quarter revenue of $3.605 billion, up 19%, and adjusted earnings of $9.47 per share, both above analyst estimates. Dupixent sales rose 33% and Libtayo 54%, while total U.S. Eylea sales fell 10%. Shares dropped 1.1% premarket. The FDA delayed a decision on a second Eylea HD syringe manufacturer; Regeneron cut its 2026 gross-margin forecast due to repairs in Ireland.
Go toTop